Pfizer blueprints €1B site in Ireland as industry's local investment spree rolls on: report

After a torrent of investments this year, Ireland is reportedly getting yet another biopharma boost courtesy of one of the industry’s biggest players.

COVID-19 juggernaut Pfizer aims to plug more than 1 billion euros into a new biomanufacturing facility at its Grange Castle site in Dublin, according to Irish news outlet The Business Post. Pfizer, which already employs 4,000 people in the country and more than 1,700 at Grange Castle alone, is reportedly in advanced planning stages for the new facility, the Post said.